{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T21:26:53Z","timestamp":1788298013411,"version":"build-2803163510"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"ALF agreement","award":["ALF-70150"],"award-info":[{"award-number":["ALF-70150"]}]},{"name":"ALF agreement","award":["ALF-73490"],"award-info":[{"award-number":["ALF-73490"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,10,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Lyme neuroborreliosis peripheral facial palsy (LNB PFP) and idiopathic PFP, Bell\u2019s palsy (BP), are the most common causes of facial palsy in borrelia-endemic areas and are clinically similar. Early treatment with corticosteroids has been shown to be effective in Bell\u2019s palsy, and antibiotics improve the outcome in LNB. However, there is a lack of knowledge on how the addition of corticosteroids to standard antibiotic treatment affects the outcome in LNB PFP.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This prospective, open trial with historical controls was conducted at 2 large hospitals in western Sweden between 2011 and 2018. Adults who presented with LNB PFP were included in the study group and were treated with oral doxycycline 200 mg twice daily for 10 days and prednisolone 60 mg once daily for 5 days, then tapered over 5 days. The historical controls were adult patients with LNB PFP included in previous studies and treated with oral doxycycline. Both groups underwent a follow-up lumbar puncture and were followed until complete recovery or for 12 months.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Fifty-seven patients were included, 27 in the study group and 30 in the control group. Two patients (7%) in the study group and 6 patients (20%) in the control group suffered from sequelae at the end follow-up. There was no statistically significant difference between the groups, either in the proportion of patients with sequelae or in the decline in cerebrospinal fluid mononuclear cell count.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Adjunctive corticosteroids neither improve nor impair the outcome for patients with LNB PFP treated with doxycycline.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciab370","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T20:00:52Z","timestamp":1619208052000},"page":"1211-1215","source":"Crossref","is-referenced-by-count":18,"title":["Adjunctive Corticosteroids for Lyme Neuroborreliosis Peripheral Facial Palsy\u2014A Prospective Study With Historical Controls"],"prefix":"10.1093","volume":"73","author":[{"given":"Sanna","family":"Avellan","sequence":"first","affiliation":[{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg,Sweden"},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Bremell","sequence":"additional","affiliation":[{"name":"Region V\u00e4stra G\u00f6taland, Sahlgrenska University Hospital, Department of Infectious Diseases, Gothenburg,Sweden"},{"name":"Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"2021100522430440200_CIT0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","article-title":"EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis","volume":"17","author":"Mygland","year":"2010","journal-title":"Eur J Neurol"},{"key":"2021100522430440200_CIT0002","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/00016488809119451","article-title":"Tick-borne borreliosis and facial palsy","volume":"105","author":"Olsson","year":"1988","journal-title":"Acta Otolaryngol"},{"key":"2021100522430440200_CIT0003","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000276740","article-title":"Borreliosis as a cause of peripheral facial palsy: a multi-center study","volume":"57","author":"Engervall","year":"1995","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"2021100522430440200_CIT0004","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.ttbdis.2018.11.019","article-title":"Borrelia burgdorferi sensu lato infection in patients with peripheral facial palsy","volume":"10","author":"Rojko","year":"2019","journal-title":"Ticks Tick Borne Dis"},{"key":"2021100522430440200_CIT0005","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1007\/s00415-019-09387-w","article-title":"Differential diagnosis of peripheral facial nerve palsy: a retrospective clinical, MRI and CSF-based study","volume":"266","author":"Zimmermann","year":"2019","journal-title":"J Neurol"},{"key":"2021100522430440200_CIT0006","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00415-005-0715-1","article-title":"Acute peripheral facial palsy in adults","volume":"252","author":"Lj\u00f8stad","year":"2005","journal-title":"J Neurol"},{"key":"2021100522430440200_CIT0007","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00405-008-0646-4","article-title":"Management of peripheral facial nerve palsy","volume":"265","author":"Finsterer","year":"2008","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"2021100522430440200_CIT0008","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/000164802760370736","article-title":"Bell\u2019s palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies","author":"Peitersen","year":"2002","journal-title":"Acta Otolaryngol Suppl"},{"key":"2021100522430440200_CIT0009","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1080\/00365540510027228","article-title":"Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis","volume":"37","author":"Borg","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"2021100522430440200_CIT0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1086\/515145","article-title":"Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis","volume":"28","author":"Dotevall","year":"1999","journal-title":"Clin Infect Dis"},{"key":"2021100522430440200_CIT0011","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","article-title":"Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial","volume":"7","author":"Lj\u00f8stad","year":"2008","journal-title":"Lancet Neurol"},{"key":"2021100522430440200_CIT0012","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors","volume":"17","author":"Lj\u00f8stad","year":"2010","journal-title":"Eur J Neurol"},{"key":"2021100522430440200_CIT0013","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S1474-4422(08)70221-7","article-title":"Prednisolone and valaciclovir in Bell\u2019s palsy: a randomised, double-blind, placebo-controlled, multicentre trial","volume":"7","author":"Engstr\u00f6m","year":"2008","journal-title":"Lancet Neurol"},{"key":"2021100522430440200_CIT0014","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa072006","article-title":"Early treatment with prednisolone or acyclovir in Bell\u2019s palsy","volume":"357","author":"Sullivan","year":"2007","journal-title":"N Engl J Med"},{"key":"2021100522430440200_CIT0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.410300212","article-title":"Lyme neuroborreliosis: a new sensitive diagnostic assay for intrathecal synthesis of Borrelia burgdorferi\u2013specific immunoglobulin G, A, and M","volume":"30","author":"Hansen","year":"1991","journal-title":"Ann Neurol"},{"key":"2021100522430440200_CIT0016","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/clinchem\/37.7.1153","article-title":"Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain","volume":"37","author":"Reiber","year":"1991","journal-title":"Clin Chem"},{"key":"2021100522430440200_CIT0017","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.cmi.2018.04.007","article-title":"Diagnostic value of cerebrospinal fluid CXCL13 for acute Lyme neuroborreliosis. A systematic review and meta-analysis","volume":"24","author":"Rupprecht","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"2021100522430440200_CIT0018","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"Dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"N Engl J Med"},{"key":"2021100522430440200_CIT0019","doi-asserted-by":"crossref","first-page":"814.e1","DOI":"10.1016\/j.cmi.2016.06.019","article-title":"Betamethasone and dexamethasone in adult community-acquired bacterial meningitis: a quality registry study from 1995 to 2014","volume":"22","author":"Glimaker","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"2021100522430440200_CIT0020","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1136\/jnnp.2004.049676","article-title":"Evaluation of combination therapy using aciclovir and corticosteroid in adult patients with herpes simplex virus encephalitis","volume":"76","author":"Kamei","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2021100522430440200_CIT0021","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1529-8027.2008.00161.x","article-title":"Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy","volume":"13","author":"Sch\u00e4fers","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"2021100522430440200_CIT0022","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/000348940611500410","article-title":"Detection of herpes simplex and varicella-zoster viruses in patients with Bell\u2019s palsy by the polymerase chain reaction technique","volume":"115","author":"Stjernquist-Desatnik","year":"2006","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"2021100522430440200_CIT0023","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/lary.26273","article-title":"Steroid use in Lyme disease-associated facial palsy is associated with worse long-term outcomes","volume":"127","author":"Jowett","year":"2017","journal-title":"Laryngoscope"},{"key":"2021100522430440200_CIT0024","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.diagmicrobio.2018.03.016","article-title":"Outcome of facial palsy from Lyme disease in prospectively followed patients who had received corticosteroids","volume":"91","author":"Wormser","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2021100522430440200_CIT0025","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/clinids\/17.4.708","article-title":"Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis","volume":"17","author":"van Dam","year":"1993","journal-title":"Clin Infect Dis"},{"key":"2021100522430440200_CIT0026","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/00365540110080313","article-title":"Three major Lyme Borrelia genospecies (Borrelia burgdorferi sensu stricto, B. afzelii and B. garinii) identified by PCR in cerebrospinal fluid from patients with neuroborreliosis in Sweden","volume":"34","author":"Ornstein","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"2021100522430440200_CIT0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/cid\/ciaa1215","article-title":"Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 Guidelines for the Prevention, Diagnosis and Treatment of Lyme Disease","volume":"72","author":"Lantos","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2021100522430440200_CIT0028","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrneurol.2015.121","article-title":"Lyme neuroborreliosis-epidemiology, diagnosis and management","volume":"11","author":"Koedel","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"2021100522430440200_CIT0029","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s10096-020-03861-4","article-title":"The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study","volume":"39","author":"Knudtzen","year":"2020","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2021100522430440200_CIT0030","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1128\/AAC.33.7.1078","article-title":"Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis","volume":"33","author":"Dotevall","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"2021100522430440200_CIT0031","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/00016489.2019.1578411","article-title":"Comparison of the efficacy of various doses of steroids for acute facial palsy","volume":"139","author":"Nam","year":"2019","journal-title":"Acta Otolaryngol"},{"key":"2021100522430440200_CIT0032","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MAO.0b013e3181ab31af","article-title":"Recovery of facial movement and facial synkinesis in Bell\u2019s palsy patients","volume":"30","author":"Kanaya","year":"2009","journal-title":"Otol Neurotol"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciab370\/38858996\/ciab370.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/1211\/40511995\/ciab370.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/73\/7\/1211\/40511995\/ciab370.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T01:00:36Z","timestamp":1633741236000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/73\/7\/1211\/6255702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":32,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,4,27]]},"published-print":{"date-parts":[[2021,10,5]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciab370","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,4,27]]}}}